LAB
NASDAQ
US
Standard BioTools Inc. - Common Stock
$0.91
▼ $-0.01
(-1.09%)
Vol 1.6M
6
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$492.2M
ROE
-29.3%
Margin
-99.6%
D/E
0.07
Beta
1.32
52W
$1–$2
Wall Street Consensus
7 analysts · Apr 20262
Strong Buy
2
Buy
3
Hold
0
Sell
0
Strong Sell
57.1%
Buy Rating
Price Chart
Similar Stocks
MLAB
Mesa Laboratories Inc
$433.5M
CYRX
Cryoport Inc
P/E 7.1
$480.7M
MRVI
Maravai LifeSciences Holdings Inc
$831.0M
NAUT
Nautilus Biotechnology Inc
$246.3M
PACB
Pacific Biosciences of California Inc
$564.6M
OABI
OmniAb Inc
$266.3M
ATLN
Atlantic International Corp
$77.8M
QTRX
Quanterix Corp
$297.1M
TKNO
Alpha Teknova Inc
$203.4M
CDXS
Codexis Inc
$147.2M
Earnings
Beat rate: 50.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $-0.07 | $0.05 | +$0.12 |
| Sep 2025 | $-0.06 | $-0.09 | $-0.03 |
| Jun 2025 | $-0.08 | $-0.09 | $-0.01 |
| Mar 2025 | $-0.08 | $-0.07 | +$0.01 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Revenue | — | $46.7M | $40.8M | $21.8M | $19.6M | $23.8M |
| Net Income | — | -$34.1M | -$26.0M | -$33.5M | -$34.7M | $19.3M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -26.2% | -27.6% | -26.2% | -26.2% | -29.3% | -29.3% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -153.8% | -78.2% | -78.1% | -78.1% | -99.5% | -99.5% |
| Gross Margin | 48.8% | 47.0% | 49.0% | 49.0% | 47.9% | 47.9% |
| D/E Ratio | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 |
| Current Ratio | 5.16 | 6.12 | 5.16 | 5.16 | 4.38 | 4.38 |
Key Ratios
ROA (TTM)
-22.4%
P/S (TTM)
3.82
P/B
1.4
EPS (TTM)
$-0.34
CF/Share
$-0.78
Rev Growth 3Y
+10.1%
52W High
$2.14
52W Low
$0.92
$0.92
52-Week Range
$2.14
Financial Health
Net Debt
-$90.0M
Cash
$120.9M
Total Debt
$30.8M
As of Dec 31, 2025
How does LAB compare to Life Sciences Tools & Services peers?
Peer group: Small-cap Life Sciences Tools & Services ($300M+) · 25 companies
LAB valuation vs Life Sciences Tools & Services peers
P/E ratio
—
▼
0%
below
peers
(32.5)
vs Peers
vs Industry
Fair value
P/S ratio
3.8
▲
0%
above
peers
(3.8)
vs Peers
vs Industry
Fair value
P/B ratio
1.4
▼
63%
below
peers
(3.7)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(0.5%)
vs Peers
vs Industry
Low yield
LAB profitability vs Life Sciences Tools & Services peers
ROE
-29.3%
▼
796%
below
peers
(-3.3%)
vs Peers
vs Industry
Weak
Net margin
-99.6%
▼
960%
below
peers
(-9.4%)
vs Peers
vs Industry
Weak
Gross margin
47.9%
▼
0%
below
peers
(48.0%)
vs Peers
vs Industry
In line
ROA
-22.4%
▼
762%
below
peers
(-2.6%)
vs Peers
vs Industry
Weak
LAB financial health vs Life Sciences Tools & Services peers
D/E ratio
0.1
▼
100%
below
peers
(36.5)
vs Peers
vs Industry
Low debt
Current ratio
4.4
▲
29%
above
peers
(3.4)
vs Peers
vs Industry
Below avg
Beta
1.3
▼
7%
below
peers
(1.4)
vs Peers
vs Industry
Less volatile
LAB fundamentals radar
LAB
Peer median
Industry
LAB profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
LAB vs peers: key metrics
Latest News
Astera Labs: A Strong Contender in the AI Chip Market
Nasdaq · Apr 04
Why Planet Labs Stock Climbed 15.8% In March
Nasdaq · Apr 03
Labour challenges Farage over cost of private jet trip to Maldives
The Guardian · Apr 03
Ukraine Becomes World's AI Weapons Laboratory
ZeroHedge · Apr 03
Why EchoStar and Rocket Lab Stocks Could Be Top Buys Ahead of …
Yahoo Finance · Mar 31